SCHEMBL3472897

SCHEMBL3472897

O=c1[nH]c(=O)c2ccc3ccccc3c2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.53
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
PARP1 P09874 2/20 0.52
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52
CDC25A P30304 1/20 0.48
CDC25C P30307 1/20 0.48
MCL1 Q07820 1/20 0.47
TYMP P19971 1/20 0.46
HPRT1 P00492 1/20 0.43
GAA P10253 1/20 0.43
CSNK2A2 P19784 1/20 0.42
CSNK2B P67870 1/20 0.42
CSNK2A1 P68400 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL424330 0.82 KIF11 (0.60) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL1838221 0.78 KDM4E (0.61) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL23530348 0.78 KIF11 (0.59) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL5466693 0.77 KIF11 (0.75) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL29368226 0.77 KIF11 (0.75) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL30914261 0.77 KIF11 (0.75) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL31454054 0.76 DAO (0.52) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL33523872 0.73 KIF11 (0.69) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL29250372 0.73 KIF11 (0.69) KIF11KDM4EALDH1A1HPGDHTT
SCHEMBL28758305 0.73 KIF11 (0.69) KIF11KDM4EALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-9297400-A None JP disclosed
US-8193430-B2 Methods for separating carbon nanotubes THE UNIVERSITY OF CONNECTICUT (US) 2012-06-05 US disclosed
US-20100044230-A1 METHODS FOR SEPARATING CARBON NANOTUBES UNIVERSITY OF CONNECTICUT (US) 2010-02-25 US disclosed
US-6183934-B1 FOE USE IN FORMATION OF PATTERN OF INSULATION FILM, PASSIVATION FILM, .ALPHA.-RAY SHIELDING FILM, OPTICAL WAVEGUIDE KABUSHIKI KAISHA TOSHIBA (JP) 2001-02-06 US disclosed
US-6159654-A Negative photosensitive polymer composition of a thermosetting polymer precursor curable by cyclodehydration upon heating KABUSHIKI KAISHA TOSHIBA (JP) 2000-12-12 US disclosed
US-6001517-A A THERMOSETTING POLYMER WHICH CAN BE CURED THROUGH CYCLODEHYDRATION UPON HEATING AND A CURE ACCELERATOR WHICH CAN BE DEACTIVATED OF ITS CURE ACCELERATION PROPERTY BY IRRIDIATION OF LIGHT KABUSHIKI KAISHA TOSHIBA (JP) 1999-12-14 US disclosed
JP-H09297400-A NEGATIVE TYPE PHOTOSENSITIVE POLYMER RESIN COMPOSITION, PATTERN FORMING METHOD USING SAME AND ELECTRONIC PARTS TOSHIBA CORP 1997-11-18 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100044230-A1 METHODS FOR SEPARATING CARBON NANOTUBES FSCN1, TTPA, FLNB KIF11 747/4885KDM4E 4262/4885ALDH1A1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.